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In an experimental vaccine model, mice were primed
three times with plasmids encoding multiple subtypes (A,
B and C) of gag, envelope (env) and reverse transcriptase
(RT) and adjuvant rGM-CSF followed by modified vacci-
nica Ankara (MVA) with the recombinant form A_E, in
theory providing protection against HIV subtypes A-E. The
cellular responses, as measured by IFN-gamma secretion
gave up to 2000 gag-specific SFC/million PBMC. The
humoral and cellular responses were further increased by
the MVA-boosts with env and gag specific ELISpot
responses above 3500 secreting/106  cells. Intracellular
cytokine staining showed remarkably high numbers
(~15%) of gag and env specific CD8+ T cells. This paved
the way for our clinical trial with the multigene/multisub-
type DNA plasmids boosted with the MVA construct.
Conclusions: This preclinical study clearly shows the
potential of combining these particular DNA and MVAs in
a prime/boost regimen and that it is possible to induce a
strong and broad humoral and cellular response directed
against several parts of HIV as well as to several subtypes
of the virus.
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